Appendix 3Y - Change of Director’s Interest Notice
CLINUVEL has entered a formal collaboration with four of the world’s leading...
Read More
CLINUVEL Confirms AGM Date
Melbourne, Australia, 13 September 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...
Read More
CLINUVEL Vitiligo Expert Panel
CLINUVEL has entered a formal collaboration with four of the world’s leading...
Read More
SCENESSE® in adolescent EPP study
Melbourne, Australia, 5 September 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...
Read More
Technical Note: DNA Damage and Repair
This Technical Note provides further detail on the current standards of care...
Read More
Two grounds of Appeal upheld by NICE Panel
In an announcement released today, CLINUVEL provided an updated on the outcome...
Read More
CLINUVEL escalates PRÉNUMBRA® to moderate/severe stroke patients
CLINUVEL announced the escalation of PRÉNUMBRA® Instant to moderate-to-severe and severe stroke...
Read More
Expansion of CLINUVEL’s global porphyria programs
CLINUVEL today released an update on the use its drug SCENESSE® (afamelanotide...
Read More
Technical note: Arterial Ischaemic Stroke (AIS)
This Technical Note provides further detail on the current standards of care...
Read More
DNA Repair data presented at American Academy of Dermatology Meeting
First results of afamelanotide in xeroderma pigmentosum C (XPC) presented to Photodermatology...
Read More
PRÉNUMBRA® Formulation Completed For Clinical Trial Use
CLINUVEL today announced the completion of manufacture of the first cGMP batch...
Read More
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population - Technical Note
Melbourne, Australia, 02 February 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...
Read More
CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals
Results released today from a clinical study have shown that the drug...
Read More
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population
Melbourne, Australia, 02 February 2023 ASX: CUV Börse Frankfurt: UR9 ADR Level...
Read More
Media release: CLINUVEL Trial Results Show Drug Reduces DNA Damage
Results from a clinical trial in a genetic DNA repair disorder show...
Read More